Outcomes after incomplete early colon cancer removal
Part of Cancer, Digestive system clinical trials.
This study follows patients who had early colon cancer removed by endoscopy (a camera procedure) but the removal was incomplete. Researchers will track what happens when patients either have surgery afterward or are closely watched instead, to understand the best next steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have early-stage colon cancer confirmed by a tissue biopsy
- You had your cancer removed using an endoscope (a thin camera tube inserted through the colon)
- Your pathology report shows the removal was incomplete (for example: cancer at the edges of what was removed, deep invasion, poor-quality cells, or spread to blood vessels)
- You have complete medical records and follow-up information available
- After your endoscopic removal, you either had additional surgery or have been under surveillance (close monitoring) for at least 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with early-stage colon cancer (stage II high-risk or stage III low-risk) that is not MSI-H. It uses a blood test (MRD) to see if you can safely delay or skip extra chemotherapy after surgery, based on whether the test finds any leftover cancer cells.
This trial compares surgery versus an endoscopic procedure for people who had a colon polyp removed but some cancer cells may still be present at the edges. The goal is to see which approach leads to better outcomes and fewer side effects for early-stage colon cancer.
This study follows patients who are having surgery to remove a specific type of flat colon growth. It aims to see how safe and effective a “selective” approach is, based on what the growth looks like and your situation.
This study looks at how well surgery works for people with colorectal cancer that has not spread to distant organs. It mainly includes patients who can have the tumor completely removed and accurately staged using lymph node samples.
This trial compares a newer, less invasive endoscopic procedure with standard surgery for people who have a small, early-stage colon cancer. The goal is to see if the endoscopic treatment is as effective as surgery while being gentler on the body.
This study follows people who had early-stage esophageal cancer removed with a minimally invasive procedure (ESD) to see how they do over time. It aims to understand how often the cancer comes back or spreads, and what factors might affect that.
Hear when a new Early Colorectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.